4D Molecular Therapeutics (FDMT) Stock Price & Financial Analysis
4D Molecular Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About 4D Molecular Therapeutics
What is the current stock price for FDMT?
As of the latest trading session, FDMT stock trades at $9.66. The 52-week range is $3.68–$12.34, with a day range of $9.45–$9.97.
What is the P/E ratio for FDMT?
The P/E ratio (Price-to-Earnings) for FDMT is shown in the Key Statistics section. This valuation metric helps compare 4D Molecular Therapeutics, Inc. to industry peers.
Does FDMT pay dividends?
4D Molecular Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for FDMT?
Based on 7 analysts, the consensus for FDMT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of FDMT?
4D Molecular Therapeutics's market capitalization is $657.5M, classifying it as a small-cap company. 4D Molecular Therapeutics operates in the Healthcare sector within the Biotechnology industry.